Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.360.360.340.340.70

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.36 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.36
Mar20230.36
Mar20220.34
Mar20210.34
Mar20200.70

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34
0.00
Mar2021 0.34
-51.43
Mar2020 0.7 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses